200 related articles for article (PubMed ID: 8157675)
1. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor.
Tartare S; Mothe I; Kowalski-Chauvel A; Breittmayer JP; Ballotti R; Van Obberghen E
J Biol Chem; 1994 Apr; 269(15):11449-55. PubMed ID: 8157675
[TBL] [Abstract][Full Text] [Related]
2. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants.
Schumacher R; Soos MA; Schlessinger J; Brandenburg D; Siddle K; Ullrich A
J Biol Chem; 1993 Jan; 268(2):1087-94. PubMed ID: 7678247
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1.
Mulligan C; Rochford J; Denyer G; Stephens R; Yeo G; Freeman T; Siddle K; O'Rahilly S
J Biol Chem; 2002 Nov; 277(45):42480-7. PubMed ID: 12213819
[TBL] [Abstract][Full Text] [Related]
4. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
[TBL] [Abstract][Full Text] [Related]
5. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function.
Faria TN; Blakesley VA; Kato H; Stannard B; LeRoith D; Roberts CT
J Biol Chem; 1994 May; 269(19):13922-8. PubMed ID: 8188672
[TBL] [Abstract][Full Text] [Related]
6. Differential signaling to glycogen synthesis by the intracellular domain of the insulin versus the insulin-like growth factor-1 receptor. Evidence from studies of TrkC-chimeras.
Kalloo-Hosein HE; Whitehead JP; Soos M; Tavaré JM; Siddle K; O'Rahilly S
J Biol Chem; 1997 Sep; 272(39):24325-32. PubMed ID: 9305889
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
[TBL] [Abstract][Full Text] [Related]
9. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors.
Takata Y; Kobayashi M
Diabete Metab; 1994; 20(1):31-6. PubMed ID: 8056133
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression.
Dupont J; Dunn SE; Barrett JC; LeRoith D
Recent Prog Horm Res; 2003; 58():325-42. PubMed ID: 12795426
[TBL] [Abstract][Full Text] [Related]
12. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways.
Miele C; Rochford JJ; Filippa N; Giorgetti-Peraldi S; Van Obberghen E
J Biol Chem; 2000 Jul; 275(28):21695-702. PubMed ID: 10777488
[TBL] [Abstract][Full Text] [Related]
13. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.
Rowzee AM; Ludwig DL; Wood TL
Endocrinology; 2009 Aug; 150(8):3611-9. PubMed ID: 19406949
[TBL] [Abstract][Full Text] [Related]
16. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.
Scalia P; Heart E; Comai L; Vigneri R; Sung CK
J Cell Biochem; 2001; 82(4):610-8. PubMed ID: 11500939
[TBL] [Abstract][Full Text] [Related]
18. Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor.
Goalstone ML; Leitner JW; Wall K; Dolgonos L; Rother KI; Accili D; Draznin B
J Biol Chem; 1998 Sep; 273(37):23892-6. PubMed ID: 9727002
[TBL] [Abstract][Full Text] [Related]
19. The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor.
Soni P; Lakkis M; Poy MN; Fernström MA; Najjar SM
Mol Cell Biol; 2000 Jun; 20(11):3896-905. PubMed ID: 10805733
[TBL] [Abstract][Full Text] [Related]
20. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components.
Dalle S; Ricketts W; Imamura T; Vollenweider P; Olefsky JM
J Biol Chem; 2001 May; 276(19):15688-95. PubMed ID: 11278773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
